Sotera Health Company Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Sotera Health Company Common Stock trades at $17.68 (market cap $5.20B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Sotera Health Company Common Stock is far larger — about 2.9× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is more actively traded (1,782,836 versus 1,647,777). Which is the better fit depends on your goals — on Pluang, investors hold Sotera Health Company Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SHC | VIR | |
|---|---|---|
Market Cap | $5.20B | $1.80B |
Volume | 1,647,777 | 1,782,836 |
Sector | Health | Health |
52-Week High | $19.57 | $11.78 |
52-Week Low | $13.13 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $7.11B | $1.36B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Sotera Health Company is a US provider of sterilization and lab testing services for the healthcare industry, operating through its Sterigenics, Nordion, and Nelson Labs businesses.
Read more on SHC →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →